Effect of Bevacizumab on Pterygium: A Case Series Study
Journal of Ophthalmic and Optometric Sciences · 15.06.2025
DOI: 10.22037/joos.v8i4.48650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 15.06.2025. Verfasst von Seyed Hashem Daryabari und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose: to study evaluate the effectiveness of a single subconjunctival injection of bevacizumab (Avastin), an anti-vascular endothelial growth factor (VEGF) agent, in reducing pterygium size and vascularization among patients with primary pterygium.Patients and Methods: Seventeen patients with primary pterygium were enrolled in this case series study. Each patient received a single subconjunctival injection of 1.25 mg bevacizumab. Follow-up evaluations were conducted at one week, one month, and three months post-injection. The primary outcomes included changes in symptoms such as itching, redness, tearing, and burning, as well as pterygium size and vascularization. Statistical analysis was performed using Repeated Measures ANOVA and Paired T-tests.
Results
Itching significantly decreased within the first week and remained stable at three months. Pterygium vascularization was also reduced. However, changes in pterygium size, astigmatism, and refraction were not statistically significant. No serious adverse effects were reported.
Conclusion
A single dose injection of subconjunctival bevacizumab significantly reduces vascularization and itching in pterygium. However, its impact on pterygium size remains unclear. While surgical excision remains the gold standard, subconjunctival bevacizumab offers an alternative treatment approach for patients seeking a minimally invasive alternative. Further studies are needed to determine optimal dosing strategies and long-term effects.
Schlagwörter
Zitieren
APA
Daryabari, S. H., Hassani, M., & Alishiri, A. (2025). Effect of Bevacizumab on Pterygium: A Case Series Study. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v8i4.48650
Vancouver
Daryabari SH, Hassani M, Alishiri A. Effect of Bevacizumab on Pterygium: A Case Series Study. Journal of Ophthalmic and Optometric Sciences. 2025. doi:10.22037/joos.v8i4.48650
BibTeX
@article{Daryabari2025,
author = {Daryabari, Seyed Hashem and Hassani, Mahmood and Alishiri, Aliagha},
title = {Effect of Bevacizumab on Pterygium: A Case Series Study},
journal = {Journal of Ophthalmic and Optometric Sciences},
year = {2025},
doi = {10.22037/joos.v8i4.48650}
}
EUVIMED